Cargando…
Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe
OBJECTIVE: To develop and validate a novel, microsimulation model that accounts for the prevalence and incidence of age-associated dementias (AAD), disease progression and associated mortality. DESIGN, DATA SOURCES AND OUTCOME MEASURES: We developed the AAD policy (AgeD-Pol) model, a microsimulation...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260808/ https://www.ncbi.nlm.nih.gov/pubmed/35793913 http://dx.doi.org/10.1136/bmjopen-2021-056546 |
_version_ | 1784742125468909568 |
---|---|
author | Hyle, Emily P Foote, Julia H A Shebl, Fatma M Qian, Yiqi Reddy, Krishna P Mukerji, Shibani S Wattananimitgul, Nattanicha Viswanathan, Anand Schwamm, Lee H Pandya, Ankur Freedberg, Kenneth A |
author_facet | Hyle, Emily P Foote, Julia H A Shebl, Fatma M Qian, Yiqi Reddy, Krishna P Mukerji, Shibani S Wattananimitgul, Nattanicha Viswanathan, Anand Schwamm, Lee H Pandya, Ankur Freedberg, Kenneth A |
author_sort | Hyle, Emily P |
collection | PubMed |
description | OBJECTIVE: To develop and validate a novel, microsimulation model that accounts for the prevalence and incidence of age-associated dementias (AAD), disease progression and associated mortality. DESIGN, DATA SOURCES AND OUTCOME MEASURES: We developed the AAD policy (AgeD-Pol) model, a microsimulation model to simulate the natural history, morbidity and mortality associated with AAD. We populated the model with age-stratified and sex-stratified data on AAD prevalence, AAD incidence and mortality among people with AAD. We first performed internal validation using data from the Adult Changes in Thought (ACT) cohort study. We then performed external validation of the model using data from the Framingham Heart Study, the Rotterdam Study and Kaiser Permanente Northern California (KPNC). We compared model-projected AAD cumulative incidence and mortality with published cohort data using mean absolute percentage error (MAPE) and root-mean-square error (RMSE). RESULTS: In internal validation, the AgeD-Pol model provided a good fit to the ACT cohort for cumulative AAD incidence, 10.4% (MAPE, 0.2%) and survival, 66.5% (MAPE, 8.8%), after 16 years of follow-up among those initially aged 65–69 years. In the external validations, the model-projected lifetime cumulative incidence of AAD was 30.5%–32.4% (females) and 16.7%–23.0% (males), using data from the Framingham and Rotterdam cohorts, and AAD cumulative incidence was 21.5% over 14 years using KPNC data. Model projections demonstrated a good fit to all three cohorts (MAPE, 0.9%–9.0%). Similarly, model-projected survival provided good fit to the Rotterdam (RMSE, 1.9–3.6 among those with and without AAD) and KPNC cohorts (RMSE, 7.6–18.0 among those with AAD). CONCLUSIONS: The AgeD-Pol model performed well when validated to published data for AAD cumulative incidence and mortality and provides a useful tool to project the AAD disease burden for health systems planning in the USA. |
format | Online Article Text |
id | pubmed-9260808 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BMJ Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-92608082022-07-25 Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe Hyle, Emily P Foote, Julia H A Shebl, Fatma M Qian, Yiqi Reddy, Krishna P Mukerji, Shibani S Wattananimitgul, Nattanicha Viswanathan, Anand Schwamm, Lee H Pandya, Ankur Freedberg, Kenneth A BMJ Open Health Policy OBJECTIVE: To develop and validate a novel, microsimulation model that accounts for the prevalence and incidence of age-associated dementias (AAD), disease progression and associated mortality. DESIGN, DATA SOURCES AND OUTCOME MEASURES: We developed the AAD policy (AgeD-Pol) model, a microsimulation model to simulate the natural history, morbidity and mortality associated with AAD. We populated the model with age-stratified and sex-stratified data on AAD prevalence, AAD incidence and mortality among people with AAD. We first performed internal validation using data from the Adult Changes in Thought (ACT) cohort study. We then performed external validation of the model using data from the Framingham Heart Study, the Rotterdam Study and Kaiser Permanente Northern California (KPNC). We compared model-projected AAD cumulative incidence and mortality with published cohort data using mean absolute percentage error (MAPE) and root-mean-square error (RMSE). RESULTS: In internal validation, the AgeD-Pol model provided a good fit to the ACT cohort for cumulative AAD incidence, 10.4% (MAPE, 0.2%) and survival, 66.5% (MAPE, 8.8%), after 16 years of follow-up among those initially aged 65–69 years. In the external validations, the model-projected lifetime cumulative incidence of AAD was 30.5%–32.4% (females) and 16.7%–23.0% (males), using data from the Framingham and Rotterdam cohorts, and AAD cumulative incidence was 21.5% over 14 years using KPNC data. Model projections demonstrated a good fit to all three cohorts (MAPE, 0.9%–9.0%). Similarly, model-projected survival provided good fit to the Rotterdam (RMSE, 1.9–3.6 among those with and without AAD) and KPNC cohorts (RMSE, 7.6–18.0 among those with AAD). CONCLUSIONS: The AgeD-Pol model performed well when validated to published data for AAD cumulative incidence and mortality and provides a useful tool to project the AAD disease burden for health systems planning in the USA. BMJ Publishing Group 2022-07-06 /pmc/articles/PMC9260808/ /pubmed/35793913 http://dx.doi.org/10.1136/bmjopen-2021-056546 Text en © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) . |
spellingShingle | Health Policy Hyle, Emily P Foote, Julia H A Shebl, Fatma M Qian, Yiqi Reddy, Krishna P Mukerji, Shibani S Wattananimitgul, Nattanicha Viswanathan, Anand Schwamm, Lee H Pandya, Ankur Freedberg, Kenneth A Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe |
title | Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe |
title_full | Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe |
title_fullStr | Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe |
title_full_unstemmed | Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe |
title_short | Development and validation of the age-associated dementia policy (AgeD-Pol) computer simulation model in the USA and Europe |
title_sort | development and validation of the age-associated dementia policy (aged-pol) computer simulation model in the usa and europe |
topic | Health Policy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260808/ https://www.ncbi.nlm.nih.gov/pubmed/35793913 http://dx.doi.org/10.1136/bmjopen-2021-056546 |
work_keys_str_mv | AT hyleemilyp developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT footejuliaha developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT sheblfatmam developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT qianyiqi developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT reddykrishnap developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT mukerjishibanis developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT wattananimitgulnattanicha developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT viswanathananand developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT schwammleeh developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT pandyaankur developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope AT freedbergkennetha developmentandvalidationoftheageassociateddementiapolicyagedpolcomputersimulationmodelintheusaandeurope |